Literature DB >> 30594326

[Primary open-angle glaucoma].

S Bertaud1, V Aragno2, C Baudouin3, A Labbé3.   

Abstract

Primary open-angle glaucoma is a progressive chronic optic neuropathy, typically bilateral, that occurs after the age of 40 years. It is the second leading cause of irreversible blindness in the world. Primary open-angle glaucoma corresponds to a progressive loss of retinal ganglion cell characterized by an excavation of the optic disc associated with typical visual field defects. Elevated intraocular pressure is the main risk factor of primary open-angle glaucoma. Diagnosis and monitoring of primary open-angle glaucoma arebased on both analysis of structural alteration, by clinical examination of optic disc completed by imaging tests (Ocular Coherence Tomography), and functional alterations, by visual field tests. The only effective treatment to slow primary open-angle glaucoma progression is the reduction of the intraocular pressure with anti-glaucomatous eye drops, laser or surgical treatments.
Copyright © 2018 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-glaucomatous treatment; Champ visuel; Collyres anti-glaucomateux; Glaucome primitif à angle ouvert; Neuropathie optique; Ocular coherence tomography (OCT); Ocular coherence tomography OCT; Optic neuropathy; Primary open-angle glaucoma; Visual field

Mesh:

Substances:

Year:  2018        PMID: 30594326     DOI: 10.1016/j.revmed.2018.12.001

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  12 in total

Review 1.  Pupillary response to chromatic light stimuli as a possible biomarker at the early stage of glaucoma: a review.

Authors:  Carla Arévalo-López; Silvia Gleitze; Samuel Madariaga; Iván Plaza-Rosales
Journal:  Int Ophthalmol       Date:  2022-07-04       Impact factor: 2.031

2.  Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma.

Authors:  Asena Keles Sahin; Hasan Burhanettin Kapti; Aslihan Uzun
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 3.  Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.

Authors:  Kassahun Alula Akulo; Terin Adali; Mthabisi Talent George Moyo; Tulin Bodamyali
Journal:  Polymers (Basel)       Date:  2022-06-10       Impact factor: 4.967

4.  PBX1 attenuates H2O2-induced oxidant stress in human trabecular meshwork cells via promoting NANOG-mediated PI3K/AKT signaling pathway.

Authors:  Liang Wang; Ying Tian; Yan Cao; Qiang Ma; Shuai Zhao
Journal:  Cell Stress Chaperones       Date:  2022-10-18       Impact factor: 3.827

5.  WDR36-Associated Neurodegeneration: A Case Report Highlights Possible Mechanisms of Normal Tension Glaucoma.

Authors:  Elana Meer; Tomas S Aleman; Ahmara G Ross
Journal:  Genes (Basel)       Date:  2021-10-15       Impact factor: 4.096

6.  Extended Ganglion Cell Layer Thickness Deviation Maps With OCT in Glaucoma Diagnosis.

Authors:  Paul Lehmann; Bettina Hohberger; Robert Lämmer; Christian Mardin
Journal:  Front Med (Lausanne)       Date:  2021-06-04

7.  A Comparative Study of the Clinical Efficacy and Safety of Pneumatic Trabeculoplasty and Selective Laser Trabeculoplasty for Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

Authors:  Yanling Song; Qiujie Song; Yanhui Qin; Jinfeng Xu; Ping Chen; Hong Li; Wenjie Han
Journal:  Med Sci Monit       Date:  2021-12-27

8.  Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.

Authors:  Tamara Kralj; Antonio Kokot; Mirna Zlatar; Sanja Masnec; Katarina Kasnik Kovac; Marija Milkovic Perisa; Lovorka Batelja Vuletic; Ana Giljanovic; Sanja Strbe; Suncana Sikiric; Slaven Balog; Bojan Sontacchi; Dijana Sontacchi; Matko Buljan; Eva Lovric; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-12-31

9.  Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects.

Authors:  Kitti Kormányos; Klaudia Kovács; Orsolya Németh; Gábor Tóth; Gábor László Sándor; Anita Csorba; Cecília Nóra Czakó; Achim Langenbucher; Zoltán Zsolt Nagy; Gergely Varga; László Gopcsa; Gábor Mikala; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2021-06-18       Impact factor: 1.909

10.  Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis.

Authors:  Yan-Xiu Qi; Hong-Wei Liu; Quan Sun; Xing-Jie Su; Lin Han
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.